Find information on thousands of medical conditions and prescription drugs.

Duragesic

Duragesic (or Durogesic in europe) is the trade name of a fentanyl transdermal therapeutic system manufactured by ALZA Corporation and marketed by Janssen Pharmaceutica Products, L.P. A generic version was under development by Sandoz Laboratories, Inc, formerly Mylan Laboratories Inc. for launch in January 2005. The generic bioequivalent of Duragesic is available in 25, 50, 75, and 100 mcg dosages, while the trade name Duragesic is available in 12.5, 23, 50, 75, and 100 mcg dosages. more...

Home
Diseases
Medicines
A
B
C
D
Dacarbazine
Dactinomycin
Dalmane
Danazol
Dantrolene
Dapoxetine
Dapsone
Daptomycin
Daraprim
Darvocet
Darvon
Daunorubicin
Daunorubicin
Daypro
DDAVP
Deca-Durabolin
Deferoxamine
Delsym
Demeclocycline
Demeclocycline
Demerol
Demulen
Denatonium
Depakene
Depakote
Depo-Provera
Desferal
Desflurane
Desipramine
Desmopressin
Desogen
Desogestrel
Desonide
Desoxyn
Desyrel
Detrol
Dexacort
Dexamethasone
Dexamfetamine
Dexedrine
Dexpanthenol
Dextran
Dextromethorphan
Dextromoramide
Dextropropoxyphene
Dextrorphan
Diabeta
Diacerein
Diacetolol
Dial
Diamox
Diazepam
Diazoxide
Dibenzepin
Diclofenac
Diclohexal
Didanosine
Dieldrin
Diethylcarbamazine
Diethylstilbestrol
Diethyltoluamide
Differin
Diflucan
Diflunisal
Digitoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dihydrotachysterol
Dilantin
Dilaudid
Diltahexal
Diltiazem
Dimenhydrinate
Dimercaprol
Dimetapp
Dimethyl sulfoxide
Dimethyltryptamine
Dimetridazole
Diminazene
Diovan
Dioxybenzone
Diphenhydramine
Diphenoxylate
Dipipanone
Dipivefrine
Diprivan
Diprolene
Diproteverine
Dipyridamole
Disulfiram
Disulfiram
Dizocilpine
Dobutamine
Docetaxel
Docusate sodium
Dofetilide
Dolasetron
Dolobid
Dolophine
Domperidone
Donepezil
Dopamine
Dopram
Doral
Doramectin
Doriden
Dornase alfa
Doryx
Dostinex
Doxapram
Doxazosin
Doxepin
Doxil
Doxil
Doxorubicin
Doxy
Doxycycline
Doxyhexal
Doxylamine
Drisdol
Drixoral
Dronabinol
Droperidol
Drospirenone
Duloxetine
Durabolin
Duragesic
Duraphyl
Duraquin
Dutasteride
Dv
Dyclonine
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

The system employs a form-fill-seal technology in which a drug-laden gel is sealed between an impermeable backing and a drug-permeable release liner.

Durogesic D-Trans, available in some European countries, consists of a thinner, solid single-layer plastic patch with the fentanyl matrix-bonded in an adhesive layer.

During the period of June 2002 - June 2003, Duragesic sales totalled over one billion dollars.

Janssen Pharmaceutica Products, L.P., initiated a series of Class II Recalls in March 2004 due to a potentially life-threatening manufacturing defect. At least one fatality, possibly due to the defect, has been reported to the FDA.

Read more at Wikipedia.org


[List your site here Free!]


FDA warns health professionals about painkiller's dangers. (Duragesic) (Brief Article) : An article from: Trial $5.95 Faulty 'pain patch' cited in negligence suits. : An article from: Trial $5.95
FDA examines extended-release opioids.(News) : An article from: Family Practice News $5.95

Five lots affected: Duragesic patch recalled due to leaks
Janssen Pharmaceutica is recalling five lots of Duragesic (fentanyl transdermal system) 75-[mu]/hr patches. The affected lot numbers are 0327192, 0327193, 0327294, 0327295, and 0330362. The pat
Mylan Technologies
Mylan Technologies.(approval of generic version of Alza's Duragesic Patch)
Relapse after drug treatment among health care professionals
The prevalence of drug dependence among physicians is similar to that in the general population. Treatment consists of continuing group therapy and mutual help groups. Little is known about relapse
Pharmaceutical: top 50 packages
PHARMACEUTICAL
New formulations
Fentanyl transdermal system (Duragesic, Alza) new dosage strength (12 mcg) for the management of persistent, moderate-to-severe chronic pain requiring ...
Pain management
In its 2000-2001 standards manual for accredited healthcare facilities and agencies, the Joint Commission on Accreditation of Healthcare Organization ...
3Q results reflect ups and downs of generics pharmaceutical industry
NEW YORK -- Early November brought the good, the bad and the ugly for generic drug makers. As third quarter results came out, the top three generic drug makers demonstrated the power of me-too drug
Pain meds still on top despite addiction, crime concerns
NEW YORK -- Despite continuing gains in the treatment of other conditions like depression and lipidemia, narcotic analgesics remain the most prescribed ...

Home Contact Resources Exchange Links ebay